Drug profile · INN
secnidazole
SOLOSEC
secnidazole (SOLOSEC) is a dna inhibitor. Associated with Evofem Biosciences. Route of administration: oral. Current US regulatory status: approved.
Drug details — secnidazole
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 3
- Programs
- 0
- Data quality
- 0.89
Quick answer
secnidazole (SOLOSEC) is a dna inhibitor. Associated with Evofem Biosciences. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12280037
Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
granted -
US 12172969
Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof
granted -
US 9566232
Compositions and methods for enhancing the efficacy of contraceptive microbicides
granted
Frequently asked questions
What is secnidazole?
secnidazole (SOLOSEC) is a dna inhibitor. Associated with Evofem Biosciences. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for secnidazole?
SOLOSEC is a marketed brand name for secnidazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of secnidazole?
secnidazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.